Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factor replenishment via plasma factors
- Molecular classification
- Other (plasma-derived protein mixture)
01
Overview
Coagulation factor replenishment via plasma factors refers to the therapeutic administration of blood plasma or plasma-derived protein products to restore deficient or dysfunctional coagulation (clotting) factors in the blood. Plasma contains multiple clotting proteins—including fibrinogen, prothrombin, and Factors V, VII, VIII, IX, X, XI, and XIII—that are essential for normal hemostasis. Such replenishment is used to treat bleeding disorders (like hemophilia and von Willebrand disease), acute coagulopathy from liver failure or massive transfusion, or to reverse anticoagulation. While highly effective, plasma therapy carries risks including transfusion reactions, infection transmission, and potential for inappropriate clot formation.
- Other names
- Blood clotting factor replacementPlasma factor replacementCoagulation factor replacementFresh frozen plasma therapy
02
Mechanism of action
Replaces or supplements missing or deficient coagulation proteins to restore normal clotting
03
Biological functions
Hemostasis (blood clotting)Prevention of bleedingRestoration of deficient plasma proteins
04
Disease associations
Hemophiliavon Willebrand diseaseAcquired clotting factor deficiencies (e.g., liver disease, warfarin overdose)Cardiovascular bleeding disordersOther bleeding diatheses
05
Safety considerations
Risk of transfusion reactionsTransmission of blood-borne infections (though rare with screening)Allergic reactionsVolume overloadThromboembolic events (if excess clotting factor administered)
06
Interacting drugs
Fresh frozen plasma
3 more in the full profile.
07
Biomarkers
Coagulation factor levels (e.g., Factor VIII, Factor IX)Prothrombin time (PT)Activated partial thromboplastin time (aPTT)International normalized ratio (INR)
Beyond the preview
Go deeper on Coagulation factor replenishment via plasma factors.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Coagulation factor replenishment via plasma factors.